Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

01. Dezember 2025 11:11 ET | Quelle: Research and Markets

Post-Traumatic Stress Disorder (PTSD) Global Clinical Trials Market Review 2025

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
28. November 2025 07:08 ET | Quelle: Research and Markets

$3.38 Bn Humanized Mice Model Market Trends, Opportunity, and Forecasts, 2020-2024 & 2025-2030

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Humanized Mice Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
25. November 2025 07:00 ET | Quelle: Pasithea

Pasithea Therapeutics Announces $1 Million Award by ALS Association to Study the Efficacy, Safety, and Tolerability of PAS-004 for Treatment of ALS

-- The ALS Association is the world's leading funder of amyotrophic lateral sclerosis (ALS) research -- -- The Hoffman ALS Clinical Trial Awards Program was created to fund early- to mid-stage...
14. November 2025 05:26 ET | Quelle: Research and Markets

Inflammatory Bowel Disease Global Clinical Trials Market Review 2025: Insights on Trial Phases, Statuses, and Regional Trends

Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
21. Juli 2025 07:23 ET | Quelle: Research and Markets

CD5 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 | CD5 Therapies Reach Phase-II Trials with Less Than 10 in Pipeline

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "CD5 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025" report has been added to ...
07. Juli 2025 07:17 ET | Quelle: Research and Markets

mRNA Cancer Vaccines Clinical Trials & Future Market Outlook 2025: Personalized mRNA Cancer Vaccines Revolutionize Oncology with Neoantigen-Driven Immunotherapy

Dublin, July 07, 2025 (GLOBE NEWSWIRE) -- The "mRNA Cancer Vaccines Clinical Trials, Market Trends By Indication, Development Priority Status & Market Opportunity Insight 2025" drug pipelines...
29. April 2025 07:02 ET | Quelle: Pasithea

Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Patients in Cohort 6 from its Phase 1 Trial of PAS-004 in Advanced Cancer Patients

Pasithea Therapeutics completes Cohort 6 enrollment and dosing in Phase 1 PAS-004 trial for MAPK-driven advanced cancers; full enrollment by 2025.
25. März 2025 09:00 ET | Quelle: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference

AGOURA HILLS, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), ”), a leader in RNA-based therapeutics, announced...
27. Januar 2025 07:00 ET | Quelle: GT Biopharma, Inc.

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology...
13. Februar 2024 07:59 ET | Quelle: Pasithea

Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004

Pasithea Tx activates four U.S. sites for Phase 1 Trial of its next-gen MEK inhibitor, aiming to assess safety, efficacy, and biomarker data.

Nächste Seite